Tag: Payers
Will Real-World Evidence (RWE), Decide Your Drug’s Price in 2025?
Real-World Evidence (RWE) Will Decide Your Drug’s Price in 2025 Drug pricing in 2025 is no longer driven solely by clinical trial data. Health authorities and payers now demand proof that drugs perform well in everyday use. Real-World Evidence (RWE) has become the backbone of value-based pricing. Its ability to reflect how patients respond outside…
